Phase 2 Crigler-Najjar Syndrome Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Gene Therapy for Crigler Najjar Syndrome Type I (AlphaCN)

Crigler-Najjar Syndrome Type I

Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare5 enrolled2 locationsNCT06641154

Recruiting

Phase 2

Efficacy and Safety of GNT0003 Following Imlifidase Pre-treatment in Severe Crigler-Najjar Syndrome

Crigler-Najjar Syndrome

Genethon3 enrolled1 locationNCT06518005